dc.contributorUniv Fed Ceara
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorBruin, Veralice Meireles Sales de [UNIFESP]
dc.creatorBittencourt, Lia Rita Azeredo [UNIFESP]
dc.creatorTufik, Sergio [UNIFESP]
dc.date.accessioned2016-01-24T14:17:38Z
dc.date.accessioned2023-09-04T18:33:59Z
dc.date.available2016-01-24T14:17:38Z
dc.date.available2023-09-04T18:33:59Z
dc.date.created2016-01-24T14:17:38Z
dc.date.issued2012-01-01
dc.identifierEuropean Neurology. Basel: Karger, v. 67, n. 5, p. 257-267, 2012.
dc.identifier0014-3022
dc.identifierhttp://repositorio.unifesp.br/handle/11600/34382
dc.identifier10.1159/000335078
dc.identifierWOS:000303444900001
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8616244
dc.description.abstractSleep disorders have been frequently reported in patients with Parkinson's disease (PD). However, there is insufficient evidence to guide precise recommendations on some diagnostic and treatment strategies. Here, we review clinical studies dealing with sleep abnormalities in PD and present clinical recommendations. Previous studies describing insomnia, excessive daytime sleepiness, narcolepsy-like episodes, circadian changes, sleep-disordered breathing, rapid eye movement sleep behavior disorder, vivid dreams and restless legs syndrome are evaluated. Longitudinal studies associating sleep disorders with PD onset or clinical deterioration are rare: only one longitudinal study associated daytime sleepiness with PD onset. Evidence suggests that clinical investigations must include direct questioning about depressive symptoms, nocturnal cramps, pain, nocturia and nighttime off periods. A patient interview must be conducted regarding sleep symptoms, including nightmares, abnormal behavior during sleep, snoring, restless legs syndrome and daytime sleepiness. Initial evidence indicates that light therapy improves motor function and depression. Advice on sleep hygiene, the treatment of concomitant depression and the careful use of dopaminergic drugs and hypnosedative agents should be considered. To date, very few controlled studies are available to make a recommendation for the management of sleep-wake disturbances in PD. Copyright (C) 2012 S. Karger AG, Basel
dc.languageeng
dc.publisherKarger
dc.relationEuropean Neurology
dc.rightshttp://www.karger.com/Services/RightsPermissions
dc.rightsAcesso aberto
dc.subjectParkinson's disease
dc.subjectRapid eye movement sleep behavior disorder
dc.subjectRestless legs
dc.subjectSleep apnea
dc.subjectInsomnia
dc.subjectCircadian disorder
dc.titleSleep-Wake Disturbances in Parkinson's Disease: Current Evidence regarding Diagnostic and Therapeutic Decisions
dc.typeResenha


Este ítem pertenece a la siguiente institución